Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cambrian Biopharma

Founders Christian Angermayer James Peyer Sebastian Brunemeier

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$36M
Portfolio companies 4
Rounds per year 2.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Medical
  • Life Science
  • Health Diagnostics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cambrian Biopharma:
Typical Co-investors
Cambrian Biopharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cambrian Biopharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anblicks -
Applied Research Council China, Hong Kong, Hong Kong Island
Common Fund Connecticut, United States, Wilton
CPC & Partners Canada, Ontario, Toronto
CW Group Connecticut, Greenwich, United States
Gelt VC California, Los Angeles, United States
Kateeva California, Newark, United States
Nanyang Ventures Australia, New South Wales, Sydney
Neev Fund India, Maharashtra, Mumbai
NFX Ventures -
Pays de la Loire Participations France, Nantes, Pays de la Loire
Success Group China, Foshan, Guangdong
The Melohn Group -
TTSeed Italy, Lombardia, Milano
University of Pittsburgh Innovation Institute Pennsylvania, Pittsburgh, United States
Work.fund -
Wuxi Haohai Information Technology Anhui, China, Wuxi
Xinghao Venture Management Center -
Xinyuan Investment -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oviva Therapeutics

Biotechnology
Health Care
$11M19 May 2022 New York, New York, United States

Vita Therapeutics

Biotechnology
Medical
Therapeutics
$32M23 Jun 2021 Baltimore, Maryland, United States

Arcellx

Biopharma
Health Care
Pharmaceutical
$115M13 Apr 2021 Maryland, United States

Sensei Biotherapeutics

Biotechnology
Health Diagnostics
Life Science
Medical
Therapeutics
$30M11 Jan 2021 Maryland, United States

Sensei Biotherapeutics

Biotechnology
Health Diagnostics
Life Science
Medical
Therapeutics
$28M07 Oct 2020 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cambrian Biopharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: